Amylyx Pharmaceuticals Inc AMLX S
January 20, 2022 - 3:58am EST by
member
2022 2023
Price: 21.28 EPS 0 0
Shares Out. (in M): 56 P/E 0 0
Market Cap (in $M): 1,202 P/FCF 0 0
Net Debt (in $M): -150 EBIT 0 0
TEV (in $M): 1,050 TEV/EBIT 0 0
Borrow Cost: Available 0-15% cost

Description

    show   sort by    
You are not eligible to view 1 messages. To gain access to more recent message posts signup free for membership.
#
AUTHOR
DATE
SUBJECT
  9
member
3/08/24
Re: Re: This is not a good short
8    
  8
member
3/08/24
Re: This is not a good short
7    
  7
member
3/07/24
This is not a good short
 
  6
member
2/20/22
Re: Re: Re: Re: Re: P3 trial or PDUFA date?
5    
  4
member
1/22/22
Re: Re: Re: P3 trial or PDUFA date?
3    
  3
member
1/21/22
Re: Re: P3 trial or PDUFA date?
2    
  2
member
1/21/22
Re: P3 trial or PDUFA date?
1    
  1
member
1/21/22
P3 trial or PDUFA date?
 
  Back to top